In a groundbreaking development, scientists at Rice University in Texas have unveiled a ‘living bandage’ designed to accelerate the healing process for serious injuries. This innovative patch acts as a continuous mini factory, delivering healing proteins directly to various types of wounds.

Revolutionizing Wound Care

Chronic wounds pose a significant challenge for medical professionals due to the difficulty in delivering steady, localized signals to prompt tissue repair. Traditional treatments often fall short as fragile proteins can break down or wash away from the injury site. To address this, the Rice University team developed a cell-based patch that adheres to the wound, containing engineered cells programmed to produce and release three specific healing cytokines: IL-10, IL-12, and Transforming Growth Factor-beta.

These engineered cells are housed within a protective material that allows essential nutrients and therapeutic proteins to reach the skin while shielding the cells from the body’s immune response. The patch also incorporates a special hydrogel, enabling it to blend naturally with the wound. Future updates may include electronic components to further enhance its functionality.

Promising Results in Animal Trials

Lab tests conducted on rodents and pigs have shown promising results, with the patch successfully accelerating wound healing. Genetic analysis confirmed that the treatment activated the necessary processes for tissue repair. Professor Omid Veiseh, who leads the laboratory development at Rice Biotech Launch Pad, highlighted the potential of continuous, localized cytokine delivery in supporting key biological pathways involved in tissue repair.

The platform’s customizable nature allows for the engineered cells to be adapted to produce different combinations of proteins and growth factors tailored to individual patient needs. Study co-author Christian Schreib, Ph.D., emphasized the potential for more precise control over the healing process by tuning both the type and timing of cytokine delivery.

While the technology is still in its early stages and has not yet been tested on humans, further research is underway to explore its application in human patients. The study’s findings were published in the journal Nature Biomedical Engineering.

Original reporting: Fox News (HLL/CB) — read the source article.